跳至主要内容
临床试验/JPRN-UMIN000026074
JPRN-UMIN000026074已完成未知

Multicenter study on the effectiveness of atrial fibrillation ablation in secondary prevention of cardiogenic cerebral embolism and systemic embolism. - Study on the effect of atrial fibrillation ablation in secondary prevention of cardiogenic cerebral embolism.

Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences0 个研究点目标入组 500 人开始时间: 2017年2月10日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who have the severe sequela of cerebral embolism to such an extent that it is difficult to safely perform pulmonary artery isolation and patients who are deemed inappropriate by the attending physician due to other complications or clinical course

研究者

发起方
Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences

相似试验